231 related articles for article (PubMed ID: 33252744)
41. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
42. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
Puhar A; Montecucco C
Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
[TBL] [Abstract][Full Text] [Related]
43. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
44. Conformational dynamics of the anthrax lethal factor catalytic center.
Dalkas GA; Chasapis CT; Gkazonis PV; Bentrop D; Spyroulias GA
Biochemistry; 2010 Dec; 49(51):10767-9. PubMed ID: 21121613
[TBL] [Abstract][Full Text] [Related]
45. Proton-coupled protein transport through the anthrax toxin channel.
Finkelstein A
Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):209-15. PubMed ID: 18957378
[TBL] [Abstract][Full Text] [Related]
46. A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore.
Krantz BA; Melnyk RA; Zhang S; Juris SJ; Lacy DB; Wu Z; Finkelstein A; Collier RJ
Science; 2005 Jul; 309(5735):777-81. PubMed ID: 16051798
[TBL] [Abstract][Full Text] [Related]
47. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
Singh Y; Chaudhary VK; Leppla SH
J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473
[TBL] [Abstract][Full Text] [Related]
48. Structure of the Anthrax Protective Antigen D425A Dominant Negative Mutant Reveals a Stalled Intermediate State of Pore Maturation.
Scott H; Huang W; Andra K; Mamillapalli S; Gonti S; Day A; Zhang K; Mehzabeen N; Battaile KP; Raju A; Lovell S; Bann JG; Taylor DJ
J Mol Biol; 2022 May; 434(9):167548. PubMed ID: 35304125
[TBL] [Abstract][Full Text] [Related]
49. Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation.
Alisaraie L; Rouiller I
J Mol Model; 2016 Jan; 22(1):7. PubMed ID: 26659402
[TBL] [Abstract][Full Text] [Related]
50. Anthrax toxin channel: What we know based on over 30 years of research.
Liu W; Nestorovich EM
Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183715. PubMed ID: 34332985
[TBL] [Abstract][Full Text] [Related]
51. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
[TBL] [Abstract][Full Text] [Related]
52. [Molecular model of anthrax toxin translocation into target-cells].
Noskov AN
Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
[TBL] [Abstract][Full Text] [Related]
53. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Blachinsky E; Kobiler D
Microb Pathog; 2011 Nov; 51(5):345-51. PubMed ID: 21791242
[TBL] [Abstract][Full Text] [Related]
54. Probing the pH-dependent prepore to pore transition of Bacillus anthracis protective antigen with differential oxidative protein footprinting.
Smedley JG; Sharp JS; Kuhn JF; Tomer KB
Biochemistry; 2008 Oct; 47(40):10694-704. PubMed ID: 18785752
[TBL] [Abstract][Full Text] [Related]
55. Asp 187 and Phe 190 residues in lethal factor are required for the expression of anthrax lethal toxin activity.
Singh A; Chauhan V; Sodhi A; Bhatnagar R
FEMS Microbiol Lett; 2002 Jul; 212(2):183-6. PubMed ID: 12113932
[TBL] [Abstract][Full Text] [Related]
56. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
57. Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.
Feld GK; Thoren KL; Kintzer AF; Sterling HJ; Tang II; Greenberg SG; Williams ER; Krantz BA
Nat Struct Mol Biol; 2010 Nov; 17(11):1383-90. PubMed ID: 21037566
[TBL] [Abstract][Full Text] [Related]
58. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
Young JA; Collier RJ
Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
[TBL] [Abstract][Full Text] [Related]
59. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
[TBL] [Abstract][Full Text] [Related]
60. New insights into the functions of anthrax toxin.
Banks DJ; Ward SC; Bradley KA
Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
